Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
This data-driven approach maximizes weight loss outcomes while minimizing unnecessary supplementation
Some patients achieve desired results within 6 to 12 months of consistent therapy, while others benefit from extended treatment spanning multiple years
The SURPASS-6 trial a direct head-to-head showed tirzepatide produced significantly greater HbA1c reduction and weight loss versus semaglutide
Plan your reconstitution volumes so that each vial lasts approximately 3-4 weeks at your current dose
For example, if you always want to draw 50 units (0.50 mL) per dose for consistency: At 2.5 mg dose: Reconstitute for 5 mg/mL (2.5 divided by 5 = 0.50 mL) At 5 mg dose: Reconstitute for 10 mg/mL (5 divided by 10 = 0.50 mL) At 7.5 mg dose: Reconstitute for 15 mg/mL (7.5 divided by 15 = 0.50 mL) This "consistent draw" approach reduces the chance of dosing errors when transitioning between dose levels because you always draw the same volume
